Total
0
Shares
ECS Botanics (ASX:ECS) - Founder and MD, Alex Keach
Founder and MD, Alex Keach
Source: ECS Botanics
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • ECS Botanics (ECS) is set to stock its Extra Virgin Tasmanian Hemp Seed Oil product in Coles stores nationwide
  • The product is expected to be on shelves in October and will be stocked in the cooking oil section
  • Hemp seed oil is becoming more popular due to its environmentally friendly source of Omega 3 and its anti-inflammatory properties
  • Total revenue is uncertain at this time and no minimum volumes have yet to be confirmed
  • Shares in ECS are up 9.09 per cent, trading at 3.6 cents at 12:44 pm AEST

ECS Botanics (ECS) is set to sell its Extra Virgin Tasmanian Hemp Seed Oil product in Coles stores nationwide.

The product will be stocked in a number of Coles’ 2500 stores from October.

ECS will no longer use Just Food Australia for the distribution of its products which allows it to achieve significantly higher margins.

The hemp seed oil product will be stocked in the cooking oil section of Coles. It can be used in cooking, salads, smoothies and baking.

Hemp seed oil is becoming more popular due to its environmental source of Omega 3 and its anti-inflammatory properties.

Total revenue is uncertain at this time and no minimum volumes have yet to be confirmed.

Managing Director Alex Keach is excited with the partnership and believes the product will be well received.

“We are delighted to be supplying Coles with our premium hemp seed oil product and are confident the product will be well received by consumers,” Mr Keach said.

“As the largest retail supplier of oil in the country, we are witnessing demand for hemp seed oil steadily increase and to now have the product stocked with two of Australia’s largest supermarket retailers, we are well positioned to capitalise on market demand.

“Now that we have established a direct relationship with supermarket groups, we will take advantage of the opportunity to extend the number of products ranged with these retailers.”

Shares in ECS were up 9.09 per cent, trading at 3.6 cents at 12:44 pm AEST.

ECS by the numbers
More From The Market Herald
Rhythm Biosciences (ASX:RHY) - Chairman, Otto Buttula

" Rhythm Biosciences (ASX:RHY) nears ColoSTAT commercialisation

Cancer diagnostics technology company Rhythm Biosciences (RHY) has updated the market regarding the commercialisation of ColoSTAT.

" Epsilon (ASX:EPN) signs manufacturing agreement for Jamaican cannabis

Epsilon Healthcare (EPN) has signed a long term manufacturing agreement for Cannim’s Jamaican cannabis products.
Suda Pharmaceuticals (ASX:SUD) - CEO and MD, Michael Baker

" SUDA Pharmaceuticals (ASX:SUD) has insomnia treatment approved in Chile

SUDA Pharmaceuticals (SUD) has had its lead product, ZolpiMist, for short-term insomnia in adults, approved by the Chile Ministry of Health.
Dimerix (ASX:DXB) - Managing Director & CEO, Dr Nina Webster

" Dimerix (ASX:DXB) receives approvals to start Phase 3 kidney damage trial

Dimerix (DXB) has been granted Australian ethics and regulatory approval for its Phase 3 clinical trial in FSGS kidney patients.